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1. Introduction 
The level of active phosphorylase is the result of a 
balance between the activities of phosphorylase 
kinase and of phosphorylase phosphatase. In recent 
years, attention has been increasingly focused on the 
enzymes responsible for the dephosphorylation of 
phosphoproteins. Among them phosphorylase phos- 
phatase and the protein inhibitors [l-5] of this 
enzyme have been studied in some detail. Several types 
of phosphorylase phosphatase have been extracted 
from dog liver [6] . Two of these are present in the 
cytosol: one type of enzyme (mol. wt. 77 OOO- 
2 15 000) is spontaneously active in vitro, but is pre- 
sumed to be inhibited in vivo owing to the presence 
of small amounts of free ATP; the other is an ATP- 
Mg-dependent phosphorylase phosphatase (mol. wt 
138 000) expected to be fully active in vlvo. A third 
and still different phosphorylase phosphatase (mol. 
wt 5 1 000) is associated with particulate glycogen; it 
is active as such and presumably also active in vivo. 
Protein kinase-dependent (inhibitor-l) and -indepen- 
dent (inhibitor-2) proteins extracted from dog liver 
[3,4] inhibit the ATP-Mg-dependent phosphorylase 
phosphatase from the cytosol as well as the spontane- 
ously active enzyme associated with particulate 
glycogen [7]. The ATP-inhibited phosphatase xtract- 
ed from the cytosol is not affected by either protein 
inhibitor. 
Now we have isolated from the glycogen pellet a 
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protein factor which cancels the effect of these pro- 
tein inhibitors on phosphorylase phosphatase. 
2. Materials and methods 
The glycogen pellet and the phosphorylase phospha- 
tase (EC 3 .1.3.17) from the cytosol were prepared 
according to Goris et al. [6]. The glycogen pellet was 
dissolved in a volume of 10 mM Tris-HCl, pH 7.4, 
one-fifth of the weight of the liver. 
The preparation of the phosphorylase phosphatase 
inhibitors-l and -2 has been described [4]. Inhibitor-l 
was activated by incubation with a preparation of the 
catalytic unit [8] of protein kinase (EC 2.7.1.37) in 
the presence of 10 mM Tris-HCl, pH 7.4,0.5 mM 
ATP and 2.5 mM Mg*‘, for 15 min at 30°C; after 
boiling for 5 min denatured protein was eliminated 
by centrifugation, and the activated inhibitor-l was 
isolated by filtration through Sephadex G-25. 
The heat-stable protein deinhibitor was extracted 
from the glycogen pellet by incubation in the pre- 
sence of 1 M NaCl (added as solid salt) for 15 min at 
30°C. The supernatant (260 000 X g for 2 h), after 
addition of 2 mg/ml /3-lactoglobulin A [9] , was 
dialyzed against 10 mM Tris-HCl, pH 7.4. After boil- 
ing for 5 min the protein deinhibitor was free of any 
phosphorylase phosphatase and kinase (EC 2.7.1.38) 
activity. 
The preparation of liver phosphorylase (EC 2.4.1 .l) 
and the assay of phosphorylase phosphatase have been 
described [lo] . Phosphorylase phosphatase inhibitor 
activity was measured on 15-20 mU phosphorylase 
phosphatase. Deinhibitor activity was determined in 
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boiled preparations (5 min at 100°C) in the same 
assay system in the presence of a titrated amount of 
inhibitor that assured near-complete inhibition of 
phosphorylase phosphatase. 
Treatment of the deinhibitor with 0.7 mg/ml trypsin 
(Worthington; lyophilysed trypsin 200 U/mg) or 
1 mg/ml pronase P (Serva) in 10 m&l Tris-HCI, pH 7.4, 
during 15 min at 3O*C, was stopped by boiling for 
5 min. When trypsin was used on phosphatase prepa- 
rations, which are thermolabile, the proteolytic reac- 
tion was arrested by the addition of a four-fold excess 
(w/w> of trypsin inhibitor (type I-S from Sigma). 
3. Results and discussion 
Phosphorylase phosphatase isolated from the 
glycogen complex by DEAE-cellulose chromatography 
could be inhibited completely by inhibitor-l as well 
as by inhibitor-2 [lo] . When we examined the effect 
of the protein inhibitors on the enzyme present in 
the crude glycogen fraction the phosphorylase phos- 
phatase activity was not or only slightly affected 
although no detectable amount of inhibitor was pre- 
sent in the glycogen pellet. The phosphorylase phos- 
phatase isolated from the glycogen complex was 
inhibited by added particulate glycogen (OS-6% of a 
preparation according to Drochmans [ 1 l] ) and this 
inhibition was also observed in addition to the effect 
of the protein in~bito~-1 and -2. Therefore other 
factor(s) present in the glycogen pellet were assumed 
to be responsible for the reduced inhibition of the 
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Fig.1. Elution profile of phosphorylase phosphatase and the 
phosphorylase phosphatase deinhibitor of the glycogen pellet 
from a column of DEAE~llulose. 10 ml of the dissolved 
glycogen pellet was diluted with 2 vol. 20 mM Tris, pH 7.8, 
and applied to a DEAE-cellulose (Whatman DE-52) column 
(0.9 X 15 cm) equilibrated with 10 mM Tris-HCl, pH 7.8. 
The eluate obtained by application of a NaCl gradient in the 
same buffer, was passed immediately through a continuous 
flow dialyzing device (DOW Hollow Fiber, model b/HFD) 
for diaJysis against 10 mM Tris-HCl, pH 7.4. Fractions (3 ml) 
were collected and assayed for phosphorylase phosphatase 
and deinhibitor activity. Deinhibitor activity was measured 
on the phosphorylase phosphatase xtracted from the cyto- 
sol in the presence of 0.5 mM ATP, 2.5 mM Mg’+ and inhi- 
bitor-2. 
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Fig.2. Separation by DEAE-ceBulose chromatography of phosphorylase phosphatase and the phosphoryfase phosphatase deinhi- 
bitor of the glycogen pellet after mercaptoethanol treatment. 10 ml of the dissolved glycogen pellet was incubated during 15 min 
at 30°C with 0.2 M mercaptoethanol. The preparation was stored at -18OC for at least 1 h, thawed and diluted with 20 ml solu- 
tion containing 20 mM MES-buffer, pH 6.5, and 5 mM mercaptoethanol. DEAECellulose chromatography and assays were 
performed as detailed in fig.1, except for the elution with MES-mercaptoethanol buffer and the NaCl gradient. 
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phosphatase by the protein inhibitors. The effect of 
this factor(s) (a ‘deinhibitor’) persisted after boiling 
of the glycogen fraction for up to 30 min. 
Phospho~lase phosphatase and dein~bitor could 
not be readily separated by chromatography of the 
glycogen pellet on DEAE-cellulose (fig.1). This 
figure shows that the phosphorylase phosphatase 
extracted from the glycogen pellet by the previously 
described method IlO] still contains heat-stable 
deinhibitor, well separated from glycogen which is 
not retained by the DEAE-cellulose. Separation of the 
phosphorylase phosphatase and the dein~bitor was 
obtained when the glycogen fraction was treated with 
mercaptoethanol prior to DEAE-cellulose chromato- 
graphy (fig.2). Under these experimental conditions 
most of the dein~bitor was not retained by the 
DEAE-cellulose; asmall amount eluted with the first 
peak of phosphorylase phosphatase. The fractions 
eluting at 0.4 M NaCl contained phosphorylase phos- 
phatase, but no measurable amount of deinhibitor. 
These fractions were pooled and used for further 
experiments. 
The deinhibitor-free phosphorylase phosphatase 
was sensitive to the activated inhibitor-l as well as to 
inhibitor-2 (fig.3). The inhibition was, as might be 
expected, more pronounced than the inhibition observ- 
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Fig.3. Effect of inhibitor-l and -2 on the deinhibitor-free 
phosphorylase phosphatase prepared from the liver glycogen 
pellet. Phosphorylase phosphatase activity was measured in 
the presence of increasing concentrations of activated 
inhibitor-l (0-e) or inhibitor-Z (o-o). 
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Fig.4. Deinhibition of deinhibitor-free phosphoryiase phos- 
phatase prepared from the liver glycogen pellet. Phosphory- 
lase phosphatase activity was measured in the presence of 
7 ng activated inhibitor-l f*---•), 10 I.rg inhibitor-2 (o-o) 
or in their absence (4 ----A), and increasing concentrations of 
deinhibitor. 
ed with the glycogen phospho~lase phosphatase 
previously used [73 since the latter fraction contains 
deinhibitor. 
As shown in fig.4, the effect of both activated 
inhibitor-l and inhibitor-2 was neutralized by the 
deinhibitor. The deinhibition of phosphorylase phos- 
phatase was concentration dependent, but the effect 
of inhibitor-2 was suppressed more easily than the 
effect of the activated in~bitor-1. Similar results were 
obtained with the ATP-Mg-dependent phosphatase 
from the cytosol. Indeed this feature was made use of 
in the assays of deinhibitor activity in fig.1 and 2. 
The deinhibitor is thermostable, resisting at boiling 
during 30 min without loss of activity, and could be 
recovered quantitatively after alcohol precipitation 
(5 vol. 95% ethanol at 25%). However since the 
de~bitor is nondi~yzable, and completely destroyed 
by pronase (not shown) or trypsin (fig.S), it was con- 
cluded that the deinhibitor is a protein. 
Activity of the phosphorylase phosphatase present 
in the glycogen pellet, and isolated by DE~~ellulose 
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Fig.5. Effect of trypsin on the deinhibitor. The activity of 
deinhibitor-free phosphorylase phosphatase (20 mu) was 
measured in the presence of inhibitor-2 (8 rg) and increasing 
concentrations of untreated (o-o) or trypsin-treated 
deinhibitor (4-A). 
chromatography (fig.1) was not affected by trypsin 
treatment, but the sensitivity of the phosphatase to 
both the activated inhibitor-l and inhibitor-2 was 
increased. This observation could be accounted for 
by the destruction of the contaminating protein 
deinhibitor. 
We have considered the possibility that the deinhi- 
bitor activity would be due to a modified phosphory- 
lase phosphatase protein, devoid of phosphatase 
activity but capable of competitive binding of the 
inhibitors. However, our observations that the deinhi- 
bitor, unlike the phosphatase, is trypsin-labile, and 
that the phosphatase could be separated from the 
deinhibitor (fig.2) argue against this hypothesis. 
Furthermore heat-denaturation of the trypsin-treated 
phosphatase and of the deinhibitor-free phosphatase 
(fig.2) did not generate deinhibitor activity. 
Since glycogen synthesis requires the existence of 
phosphorylase in the inactive b form, phosphorylase 
phosphatase should be active under these conditions; 
glycogenolysis, on the other hand would evidently 
be favored by a low activity of phosphorylase phos- 
phatase. Hepatic glycogenolysis can be promoted via 
cyclic AMP and protein kinase-mediated activation of 
inhibitor-l of phosphorylase phosphatase; the reverse 
reaction is catalyzed by a protein phosphatase that is 
now under investigation. No mechanism is known for 
the regulation of inhibitor-2 activity. The association 
with liver glycogen of a deinhibitor, neutralizing both 
inhibitor-l and inhibitor-2, could constitute the 
mechanism by which phosphorylase phosphatase is 
kept in the active state during accumulation of gly- 
cogen. We speculate that during cyclic AMP-initiated 
glycogenolysis, inhibitor-l is phosphorylated and 
overcomes the protective effect of the deinhibitor. 
Such a mechanism could account for an inhibition of 
phosphorylase phosphatase during cyclic AMP-stimu- 
lated glycogenolysis. 
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